Expect sequential improvement ahead
Turnaround is here but weaker than expected
Expect domestic business to rebound from 2025
China Pharmaceutical & Healthcare: Expecting global funding recovery in the coming quarters
Apple FY1Q23 miss on macro and supply chain issues; Expect weakness to persist in near term
2Q loss reduction trend better than expectation
Natural gas HDT +14.8x YoY in Oct on low base; Expect momentum to continue; Weichai our top pick
–1H23 worse than expected on slow recovery; Maintain HOLD
what-can-we-expect-in-china-in-2018
China Property Sector – NBS 2M23 data: Strong as expected